[Clinical and experimental results of interstitial Curie-therapy combined with radiosensitizing agents in DS carcinoma of the rat and in infiltrating brain neoplasms].
D000818:Animals; D001932:Brain Neoplasms / Q000532:radiotherapy*; D001973:Bromodeoxyuridine / Q000627:therapeutic use; D002296:Carcinosarcoma / Q000188:drug therapy / Q000532:radiotherapy; D003562:Cytidine / Q000627:therapeutic use; D004806:Ependymoma / Q000188:drug therapy / Q000532:radiotherapy; D005909:Glioblastoma / Q000188:drug therapy / Q000532:radiotherapy; D006801:Humans; D007495:Iridium / Q000627:therapeutic use*; D008727:Methotrexate / Q000378:metabolism; D009837:Oligodendroglioma / Q000188:drug therapy; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use*; D051381:Rats; D013936:Thymidine / Q000378:metabolism
D011838:Radiation-Sensitizing Agents; D007495:Iridium; D003562:Cytidine; D001973:Bromodeoxyuridine; D013936:Thymidine; D008727:Methotrexate
Klinische und experimentelle Ergebnisse der interstitiellen Curie-Therapie in Kombination mit strahlensensibilisierenden Substanzen beim DS-Karzinosarkom der Ratte und infiltrierenden Hirntumoren.